Apports des biomarquers amyloïdes dans la caractérisation de la plainte mnésique du sujet âgé

Apports des biomarquers amyloïdes dans la caractérisation de la plainte mnésique du sujet âgé

Les biomarqueurs de la maladie d’Alzheimer (MA) permettraient d’identifier les processus pathologiques de la maladie plusieurs années avant l’apparition des premiers signes cliniques. Ainsi, la tomographie par émission de positons (TEP) reposant sur les radio-traceurs liant les plaques amyloïdes, a...

Full description

Bibliographic Details
Main Author:	Lilamand, Matthieu
Other Authors:	Paris Saclay
Language:	fr
Published:	2017
Subjects:	Maladie d'Alzheimer PET scanner Plaques amyloïdes Iadl Alzheimer's disease Amyloid plaques
Online Access:	http://www.theses.fr/2017SACLS342

Similar Items

ANIMAL Antidépresseurs, neuroinflammation et maladie d'alzheimer
by: Gosselin, Thomas
Published: (2016)

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques
by: Milos D. Ikonomovic, et al.
Published: (2018-06-01)

Cellules souches embryonnaires et neurales humaines : quand la PrP et l'APP "s'en mêlent" ou "s’emmêlent"
by: Radreau, Félicie
Published: (2016)

Phagocytes mononucléaires dans la maladie d'Alzheimer : caractérisation et stimulation de mécanismes cellulaires promouvant l'élimination de bêta-amyloïde
by: Michaud, Jean-Philippe
Published: (2015)

Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species
by: Xu-Qiao Chen, et al.
Published: (2019-06-01)

Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
by: Madeleine R. Brown, et al.
Published: (2020-11-01)

Talk the talk and walk the walk. Evaluation of autonomy in aging and Alzheimer disease by simulating instrumental activities of daily living: the S-IADL
by: Véronique Quaglino, et al.
Published: (2016-09-01)

Detection of activities of daily living impairment in Alzheimer's disease and mild cognitive impairment using information and communication technology
by: Sacco G, et al.
Published: (2012-12-01)

Propriétés anti-virales des peptides β-amyloïdes associés à la maladie d'Alzheimer : implication dans le développement et la progression de la maladie
by: Bourgade Karine
Published: (2016)

Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques
by: Anna Pensalfini, et al.
Published: (2014-11-01)

Bacterial Extracellular DNA Promotes β-Amyloid Aggregation
by: George Tetz, et al.
Published: (2021-06-01)

Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques
by: Tadafumi Hashimoto, et al.
Published: (2020-12-01)

Involvement of Dab1 in APP processing and β-amyloid deposition in sporadic Creutzfeldt–Jakob patients
by: R. Gavín, et al.
Published: (2010-02-01)

Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease
by: Justyna Sosna, et al.
Published: (2018-03-01)

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome
by: Matthew D. Zammit, et al.
Published: (2021-03-01)

18F-Florbetaben Amyloid PET Imaging: A Chinese Study in Cognitive Normal Controls, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
by: Yan Chang, et al.
Published: (2020-07-01)

Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer’s Disease
by: Shizuo Hatashita, et al.
Published: (2019-09-01)

Développement de nouvelles stratégies anti-amyloïdes ciblant la protéine précurseur amyloïde pour le traitement de la maladie d'alzheimer
by: Ben Aissa, Manel
Published: (2012)

Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
by: Virginia Pérez-Grijalba, et al.
Published: (2019-12-01)

Clinical utility of amyloid PET imaging in the differential diagnosis of atypical dementias and its impact on caregivers
by: Bensaïdane, Mohamed Réda
Published: (2016)

Etude de l'intéraction de la thioflavine T et de complexes de ru(ii) avec le peptide amyloïde bêta dans le cadre de la maladie d'alzheimer
by: Eury, Hélène
Published: (2013)

Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology
by: M. Mahafuzur Rahman, et al.
Published: (2021-08-01)

he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments
by: I. V. Litvinenko, et al.
Published: (2019-11-01)

Maladie d'Alzheimer : Impact extracellulaire et intracellulaire du peptide ß-amyloïde sur la transmission synaptique glutamatergique
by: Rolland, Marta
Published: (2016)

Rôle du cholestérol dans l'oligomérisation des peptides β-amyloïdes responsables de la maladie d'Alzheimer
by: Di Scala, Coralie
Published: (2014)

Modulation of the innate immune system as a potential therapeutic strategy for Alzheimer's and Multiple Sclerosis Diseases
by: Fani Maleki, Adham
Published: (2021)

Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer’s Disease with APP Osaka Mutation
by: Hiroyuki Shimada, et al.
Published: (2020-06-01)

Amyloid accumulation in Down syndrome measured with amyloid load
by: Matthew D. Zammit, et al.
Published: (2020-01-01)

Etude de la structure et de la toxicité des oligomères du peptide amyloïde-beta: implication dans la maladie d'Alzheimer
by: Sarroukh, Rabia
Published: (2011)

Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms
by: Arne Herring, et al.
Published: (2011-06-01)

Clinical Relevance of [<sup>18</sup>F]Florbetaben and [<sup>18</sup>F]FDG PET/CT Imaging on the Management of Patients with Dementia
by: Damiano Librizzi, et al.
Published: (2021-02-01)

Aβ plaques
by: Lary C Walker
Published: (2020-10-01)

Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer’s disease
by: David L. Brody, et al.
Published: (2017-08-01)

Ocena podstawowych i złożonych czynności życia codziennego pacjentów geriatrycznych po zabiegu endoprotezoplastyki stawu biodrowego / Assessment of basic and instrumental activities of daily living in geriatric patients after total hip arthroplasty
by: Puzio Grzegorz, et al.
Published: (2014-12-01)

Time between milestone events in the Alzheimer's disease amyloid cascade
by: Philip S. Insel, et al.
Published: (2021-02-01)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
by: Youn YC, et al.
Published: (2017-06-01)

Synthesis of peptidomimetics containing bifunctional diketoopiperazine scaffolds and their evaluation as modulators of amyloid-B peptide oligomerization
by: Vahdati, Leïla
Published: (2015)

Label-free vibrational imaging of different Aβ plaque types in Alzheimer’s disease reveals sequential events in plaque development
by: Dominik Röhr, et al.
Published: (2020-12-01)

Contribution of GABAergic interneurons to amyloid-β plaque pathology in an APP knock-in mouse model
by: Heather C. Rice, et al.
Published: (2020-01-01)

Istradefylline reduces memory deficits in aging mice with amyloid pathology
by: Anna G. Orr, et al.
Published: (2018-02-01)